Pharmacological challenges in chronic pancreatitis

Anne Estrup Olesen, Anne Brokjaer, Iben Wendelboe Deleuran Fischer, Isabelle Myriam Larsen

Publikation: Bidrag til bog/antologi/rapport/konference proceedingBidrag til bog/antologiForskningpeer review

Resumé

Drug absorption in patients with chronic pancreatitis might be affected by the pathophysiology of the disease. The exocrine pancreatic insufficiency is associated with changes in gastrointestinal intraluminal pH, motility disorder, bacterial overgrowth and changed pancreatic gland secretion. Together these factors can result in malabsorption and may also affect the efficacy of pharmacological intervention. The lifestyle of chronic pancreatitis patients may also contribute to gastrointestinal changes. Many patients limit their food intake because of the pain caused by eating and in some cases food intake is more or less substituted with alcohol, tobacco and coffee. Alcohol and drug interaction are known to influence the pharmacokinetics by altering either drug absorption or by affecting liver metabolism. Since patients suffering from chronic pancreatitis experience severe pain, opioids are often prescribed as pain treatment. Opioids have intrinsic effects on gastrointestinal motility and hence can modify the absorption of other drugs taken at the same time. Furthermore, the increased fluid absorption caused by opioids will decrease water available for drug dissolution and may hereby affect absorption of the drug. As stated above many factors can influence drug absorption and metabolism in patients with chronic pancreatitis. The factors may not have clinical relevance, but may explain inter-individual variations in responses to a given drug, in patients with chronic pancreatitis.
OriginalsprogEngelsk
TitelWorld Clinical Gastroenterology
RedaktørerLi Ma, Mei-Sze Chua, Samuel So
Antal sider6
Udgivelses stedPleasanton (CA)
ForlagBaishideng Publishing Group
Publikationsdato2014
Udgave1
Sider3428-3433
ISBN (Elektronisk)978-0-9914430-0-0
StatusUdgivet - 2014
NavnWorld Journal of Gastroenterology
ISSN1007-9327

Fingerprint

Chronic Pancreatitis
Pharmacology
Pharmaceutical Preparations
Opioid Analgesics
Eating
Pain
Alcohols
Exocrine Pancreatic Insufficiency
Gastrointestinal Motility
Coffee
Drug Interactions
Tobacco
Life Style
Pharmacokinetics
Water
Liver

Citer dette

Olesen, A. E., Brokjaer, A., Fischer, I. W. D., & Larsen, I. M. (2014). Pharmacological challenges in chronic pancreatitis. I L. Ma, M-S. Chua, & S. So (red.), World Clinical Gastroenterology (1 udg., s. 3428-3433). Pleasanton (CA): Baishideng Publishing Group. World Journal of Gastroenterology
Olesen, Anne Estrup ; Brokjaer, Anne ; Fischer, Iben Wendelboe Deleuran ; Larsen, Isabelle Myriam. / Pharmacological challenges in chronic pancreatitis. World Clinical Gastroenterology. red. / Li Ma ; Mei-Sze Chua ; Samuel So. 1. udg. Pleasanton (CA) : Baishideng Publishing Group, 2014. s. 3428-3433 (World Journal of Gastroenterology).
@inbook{c1054d86e2c3431e8ab750537c013033,
title = "Pharmacological challenges in chronic pancreatitis",
abstract = "Drug absorption in patients with chronic pancreatitis might be affected by the pathophysiology of the disease. The exocrine pancreatic insufficiency is associated with changes in gastrointestinal intraluminal pH, motility disorder, bacterial overgrowth and changed pancreatic gland secretion. Together these factors can result in malabsorption and may also affect the efficacy of pharmacological intervention. The lifestyle of chronic pancreatitis patients may also contribute to gastrointestinal changes. Many patients limit their food intake because of the pain caused by eating and in some cases food intake is more or less substituted with alcohol, tobacco and coffee. Alcohol and drug interaction are known to influence the pharmacokinetics by altering either drug absorption or by affecting liver metabolism. Since patients suffering from chronic pancreatitis experience severe pain, opioids are often prescribed as pain treatment. Opioids have intrinsic effects on gastrointestinal motility and hence can modify the absorption of other drugs taken at the same time. Furthermore, the increased fluid absorption caused by opioids will decrease water available for drug dissolution and may hereby affect absorption of the drug. As stated above many factors can influence drug absorption and metabolism in patients with chronic pancreatitis. The factors may not have clinical relevance, but may explain inter-individual variations in responses to a given drug, in patients with chronic pancreatitis.",
author = "Olesen, {Anne Estrup} and Anne Brokjaer and Fischer, {Iben Wendelboe Deleuran} and Larsen, {Isabelle Myriam}",
year = "2014",
language = "English",
series = "World Journal of Gastroenterology",
publisher = "Baishideng Publishing Group",
pages = "3428--3433",
editor = "Li Ma and Mei-Sze Chua and Samuel So",
booktitle = "World Clinical Gastroenterology",
edition = "1",

}

Olesen, AE, Brokjaer, A, Fischer, IWD & Larsen, IM 2014, Pharmacological challenges in chronic pancreatitis. i L Ma, M-S Chua & S So (red), World Clinical Gastroenterology. 1 udg, Baishideng Publishing Group, Pleasanton (CA), World Journal of Gastroenterology, s. 3428-3433.

Pharmacological challenges in chronic pancreatitis. / Olesen, Anne Estrup; Brokjaer, Anne; Fischer, Iben Wendelboe Deleuran; Larsen, Isabelle Myriam.

World Clinical Gastroenterology. red. / Li Ma; Mei-Sze Chua; Samuel So. 1. udg. Pleasanton (CA) : Baishideng Publishing Group, 2014. s. 3428-3433 (World Journal of Gastroenterology).

Publikation: Bidrag til bog/antologi/rapport/konference proceedingBidrag til bog/antologiForskningpeer review

TY - CHAP

T1 - Pharmacological challenges in chronic pancreatitis

AU - Olesen, Anne Estrup

AU - Brokjaer, Anne

AU - Fischer, Iben Wendelboe Deleuran

AU - Larsen, Isabelle Myriam

PY - 2014

Y1 - 2014

N2 - Drug absorption in patients with chronic pancreatitis might be affected by the pathophysiology of the disease. The exocrine pancreatic insufficiency is associated with changes in gastrointestinal intraluminal pH, motility disorder, bacterial overgrowth and changed pancreatic gland secretion. Together these factors can result in malabsorption and may also affect the efficacy of pharmacological intervention. The lifestyle of chronic pancreatitis patients may also contribute to gastrointestinal changes. Many patients limit their food intake because of the pain caused by eating and in some cases food intake is more or less substituted with alcohol, tobacco and coffee. Alcohol and drug interaction are known to influence the pharmacokinetics by altering either drug absorption or by affecting liver metabolism. Since patients suffering from chronic pancreatitis experience severe pain, opioids are often prescribed as pain treatment. Opioids have intrinsic effects on gastrointestinal motility and hence can modify the absorption of other drugs taken at the same time. Furthermore, the increased fluid absorption caused by opioids will decrease water available for drug dissolution and may hereby affect absorption of the drug. As stated above many factors can influence drug absorption and metabolism in patients with chronic pancreatitis. The factors may not have clinical relevance, but may explain inter-individual variations in responses to a given drug, in patients with chronic pancreatitis.

AB - Drug absorption in patients with chronic pancreatitis might be affected by the pathophysiology of the disease. The exocrine pancreatic insufficiency is associated with changes in gastrointestinal intraluminal pH, motility disorder, bacterial overgrowth and changed pancreatic gland secretion. Together these factors can result in malabsorption and may also affect the efficacy of pharmacological intervention. The lifestyle of chronic pancreatitis patients may also contribute to gastrointestinal changes. Many patients limit their food intake because of the pain caused by eating and in some cases food intake is more or less substituted with alcohol, tobacco and coffee. Alcohol and drug interaction are known to influence the pharmacokinetics by altering either drug absorption or by affecting liver metabolism. Since patients suffering from chronic pancreatitis experience severe pain, opioids are often prescribed as pain treatment. Opioids have intrinsic effects on gastrointestinal motility and hence can modify the absorption of other drugs taken at the same time. Furthermore, the increased fluid absorption caused by opioids will decrease water available for drug dissolution and may hereby affect absorption of the drug. As stated above many factors can influence drug absorption and metabolism in patients with chronic pancreatitis. The factors may not have clinical relevance, but may explain inter-individual variations in responses to a given drug, in patients with chronic pancreatitis.

M3 - Book chapter

T3 - World Journal of Gastroenterology

SP - 3428

EP - 3433

BT - World Clinical Gastroenterology

A2 - Ma, Li

A2 - Chua, Mei-Sze

A2 - So, Samuel

PB - Baishideng Publishing Group

CY - Pleasanton (CA)

ER -

Olesen AE, Brokjaer A, Fischer IWD, Larsen IM. Pharmacological challenges in chronic pancreatitis. I Ma L, Chua M-S, So S, red., World Clinical Gastroenterology. 1 udg. Pleasanton (CA): Baishideng Publishing Group. 2014. s. 3428-3433. (World Journal of Gastroenterology).